Duygu Derin

514 total citations
24 papers, 424 citations indexed

About

Duygu Derin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Duygu Derin has authored 24 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Duygu Derin's work include Ovarian cancer diagnosis and treatment (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Duygu Derin is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Duygu Derin collaborates with scholars based in Türkiye and United States. Duygu Derin's co-authors include Erkan Topuz, Neşe Güney, Hakan Çamlıca, Hilal Oğuz, Vildan Yasasever, Derya Duranyıldız, Faruk Taş, Adnan Aydıner, Yeşim Eralp and Pınar Saip and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Duygu Derin

24 papers receiving 416 citations

Peers

Duygu Derin

ONCOL

PRM

IMMUN

Ryo Sato Japan

Lorenzo Alonso Spain

Tomoko Ota Japan

V. R. Rozados Argentina

Luis Aparicio Spain

Brittney S. Harrington United States

Janice M. Kraniak United States

Meijin Huang China

Florence Quesada‐Calvo Belgium

Kefeng Wang China

Ryo Sato Japan

Duygu Derin

289 ×1.6

ONCOL

283 ×1.6

105 ×1.3

115 ×1.5

PRM

65 ×1.1

IMMUN

Citations per year, relative to Duygu Derin Duygu Derin (= 1×) peers Ryo Sato

Countries citing papers authored by Duygu Derin

Since Specialization

Citations

This map shows the geographic impact of Duygu Derin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duygu Derin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duygu Derin more than expected).

Fields of papers citing papers by Duygu Derin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duygu Derin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duygu Derin. The network helps show where Duygu Derin may publish in the future.

Co-authorship network of co-authors of Duygu Derin

This figure shows the co-authorship network connecting the top 25 collaborators of Duygu Derin. A scholar is included among the top collaborators of Duygu Derin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duygu Derin. Duygu Derin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vural, Burçak, Fatih Yakar, Duygu Derin, et al.. (2012). Evaluation of Glutathione S-Transferase P1 Polymorphisms (Ile105Val and Ala114Val) in Patients with Small Cell Lung Cancer. Genetic Testing and Molecular Biomarkers. 16(7). 701–706. 10 indexed citations

Oğuz, Hilal, Derya Duranyıldız, Neşe Güney, Duygu Derin, & Vildan Yasasever. (2012). Utility of Serum and Urine uPAR Levels for Diagnosis of Breast Cancer. Asian Pacific Journal of Cancer Prevention. 13(6). 2887–2889. 9 indexed citations

Saip, Pınar, et al.. (2010). Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer. Genetics and Molecular Research. 9(1). 97–106. 9 indexed citations

Demirkesen, Cüyan, et al.. (2010). Pancreatic panniculitis as the first manifestation of the pancreatic involvement during the course of a gastric adenocarcinoma. Medical Oncology. 28(1). 137–139. 7 indexed citations

Can, Gülbeyaz, Erkan Topuz, Duygu Derin, Zehra Durna, & Adnan Aydıner. (2009). Effect of Kefir on the Quality of Life of Patients Being Treated for Colorectal Cancer. Oncology nursing forum. 36(6). E335–E342. 18 indexed citations

Güney, Neşe, Hilal Oğuz, Mert Başaran, et al.. (2009). Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.. PubMed. 10(4). 669–74. 22 indexed citations

Derin, Duygu, et al.. (2008). Ovarian Carcinoma with Simultaneous Breast and Rectum Metastases. Onkologie. 31(4). 200–202. 6 indexed citations

Taş, Faruk, Duygu Derin, Neşe Güney, Adnan Aydıner, & Erkan Topuz. (2008). Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer. International Journal of Clinical Oncology. 13(4). 330–334. 7 indexed citations

Taş, Faruk, Neşe Güney, Duygu Derin, Adnan Aydıner, & Erkan Topuz. (2008). A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer. International Journal of Clinical Oncology. 13(2). 156–160. 11 indexed citations

10.

Derin, Duygu, Yeşim Eralp, Yasemin Özlük, et al.. (2008). Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer. Cancer Investigation. 26(7). 671–679. 15 indexed citations

11.

Duranyıldız, Derya, Hakan Çamlıca, Hilal Oğuz, Duygu Derin, & Vildan Yasasever. (2008). Serum levels of angiogenic factors in early breast cancer remain close to normal. The Breast. 18(1). 26–29. 16 indexed citations

12.

Topuz, Erkan, Duygu Derin, Gülbeyaz Can, et al.. (2008). Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Investigational New Drugs. 26(6). 567–572. 39 indexed citations

13.

Eralp, Yeşim, Duygu Derin, Ekrem Yavuz, et al.. (2007). MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. Annals of Oncology. 19(4). 669–674. 49 indexed citations

14.

Derin, Duygu, Hilal Oğuz, Neşe Güney, et al.. (2007). Serum IL-8 and IL-12 levels in breast cancer. Medical Oncology. 24(2). 163–168. 50 indexed citations

15.

Taş, Faruk, Duygu Derin, Neşe Güney, et al.. (2007). Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma. Lung Cancer. 57(1). 79–83. 3 indexed citations

16.

Taş, Faruk, Neşe Güney, Duygu Derin, et al.. (2007). Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer. Investigational New Drugs. 26(4). 363–368. 14 indexed citations

17.

Derin, Duygu, Hilal Oğuz, Neşe Güney, et al.. (2007). Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer. Lung Cancer. 59(2). 240–245. 60 indexed citations

18.

Güney, Neşe, Hilal Oğuz, Duygu Derin, et al.. (2007). Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer. Medical Oncology. 25(2). 194–200. 28 indexed citations

19.

Güney, Neşe, Hilal Oğuz, Duygu Derin, et al.. (2006). Serum and Urine Survivin Levels in Breast Cancer. Medical Oncology. 23(3). 335–340. 25 indexed citations

20.

Karagöl, Hakan, Duygu Derin, Mert Başaran, & Sevil Bavbek. (2005). Isolated Skeletal Muscle Recurrence of the Paranasal Sinus Lymphoma in Complete Remission. Medical Oncology. 22(3). 313–318. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact